Inici › Lupus › Texas › Houston
Assaigs clínics de Lupus a Houston, TX
13 estudis de Lupus busquen participants en centres de Houston i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
ReclutantFase 3
- Sl0044 50696, Houston
- Sl0044 50723, Houston
- Sl0044 50738, Bellaire · a 7 mi
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
ReclutantFase 2
- Prolato Clinical Research Center, Houston
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
ReclutantFase 2
- The University of Texas Health Science Center at Houston, Houston
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
ReclutantFase 3
- Novel Research LLC, Bellaire · a 7 mi
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
ReclutantFase 3
- Research Site, Houston
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
ReclutantFase 3
- Research Site, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
ReclutantFase 1
- UT MD Anderson Cancer Center, Houston
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
ReclutantFase 1
- Baylor College of Medicine, Houston
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
ReclutantFase 3
- Accurate Clinical Research, Humble · a 17 mi
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
ReclutantFase 1/2
- University of Texas MD Anderson Cancer Center, Houston
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
ReclutantFase 3
- Novel Research, LLC., Houston
- Northwest Houston Arthritis, Houston
- Rheumatology Care Center, PLLC, Bellaire · a 7 mi
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
ReclutantEstudi observacional
- M D Anderson Cancer Center, Houston
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
ReclutantFase 1/2
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
Assaigs de Lupus en altres ciutats
- New York City, NY18 estudis
- Durham, NC12 estudis
- Washington, DC10 estudis
- Miami, FL10 estudis
- Tampa, FL9 estudis
- Philadelphia, PA9 estudis
- Clearwater, FL8 estudis
- Santa Monica, CA8 estudis
- Oklahoma City, OK8 estudis
- Boston, MA8 estudis
- Los Angeles, CA8 estudis
- Chicago, IL8 estudis
Altres estudis a Houston
- Càncer de pulmó de cèl·lules no petites145 estudis
- Càncer de mama126 estudis
- Càncer (tots els tipus)121 estudis
- Càncer metastàtic104 estudis
- Càncer colorrectal102 estudis
- Càncer d'ovari89 estudis
- Leucèmia mieloide aguda85 estudis
- Càncer de pulmó78 estudis
- Càncer de pròstata76 estudis
- Càncer d'endometri68 estudis
- Càncer de pàncrees61 estudis
- Melanoma59 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.